The role of FOXOs and autophagy in cancer and metastasis-Implications in therapeutic development

Mohd Farhan1, Marta Silva1, Shuai Li1

  • 1Faculty of Health Sciences, Centre of Reproduction, Development and Aging, Institute of Translational Medicine, University of Macau, Taipa, Macau SAR, China.

Insights

Forkhead box O (FOXO) proteins and autophagy are key regulators in cancer development and metastasis. This study explores their roles in cancer progression and potential therapeutic strategies.

Area of Science:

  • Cell Biology
  • Oncology
  • Molecular Biology

Background:

  • Autophagy is a critical cellular degradation process involved in cell survival and stress responses.
  • Autophagy dysfunction is implicated in cancer development and metastasis.
  • Forkhead box O (FOXO) transcription factors regulate genes crucial for metabolism and cancer signaling.

Purpose of the Study:

  • To summarize the role of FOXO proteins in cancer.
  • To elucidate the involvement of autophagy in cancer progression.
  • To analyze the combined roles of FOXOs and autophagy in cancer metastasis and disease management.

Main Methods:

  • Literature review of studies on FOXO transcription factors.
  • Analysis of research on autophagy mechanisms in cancer.
  • Synthesis of current evidence linking FOXOs, autophagy, and cancer.

Main Results:

  • FOXO proteins regulate genes involved in cellular metabolism and cancer-related signaling pathways.
  • FOXO proteins are increasingly recognized for their involvement in autophagy regulation.
  • The interplay between FOXOs and autophagy significantly impacts cancer growth and metastasis.

Conclusions:

  • FOXO proteins and autophagy are integral to cancer biology.
  • Understanding their relationship offers potential for novel cancer treatment strategies.
  • Targeting FOXOs and autophagy may provide new avenues for cancer disease management.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.5K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.8K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.5K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
8.1K